Woodline Partners LP Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$5.4B
Holdings
586
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (586 positions)
| Stock | Value |
|---|---|
—STAR PEAK CORP II | $5.9M |
BOLT1EURBOLT BIOTHERAPEUTICS INC | $5.9M |
PRVAPRIVIA HEALTH GROUP INC | $5.9M |
BARKTHE ORIGINAL BARK COMPANY | $5.8M |
—AGILE GROWTH CORP | $5.8M |
—BCTG ACQUISITION CORP | $5.7M |
DRVNDRIVEN BRANDS HLDGS INC | $5.6M |
KURAKURA ONCOLOGY INC | $5.6M |
TBPHTHERAVANCE BIOPHARMA INC | $5.4M |
ABNBAIRBNB INC | $5.4M |
EHCENCOMPASS HEALTH CORP | $5.4M |
—BCLS ACQUISITION CORP | $5.4M |
HOLXHOLOGIC INC | $5.3M |
TIXTTELUS INTL CDA INC | $5.1M |
—REVOLUTION HEALTHCAR AQ CORP | $5.0M |
2L9BLUEPRINT MEDICINES CORP | $5.0M |
—PROMETHEUS BIOSCIENCES INC | $5.0M |
IDYAIDEAYA BIOSCIENCES INC | $5.0M |
HNSTHONEST CO INC | $5.0M |
SSENTINELONE INC | $5.0M |
VTRSVIATRIS INC | $5.0M |
ULCCFRONTIER GROUP HLDGS INC | $4.9M |
—RIBBIT LEAP LTD | $4.9M |
CCIXCHURCHILL CAPITAL CORP VII | $4.9M |
—ACCELERATE ACQUISITION CORP | $4.8M |
DOYUDOUYU INTL HLDGS LTD | $4.8M |
HSKAEURHESKA CORP | $4.8M |
ELANELANCO ANIMAL HEALTH INC | $4.7M |
GLUEMONTE ROSA THERAPEUTICS INC | $4.7M |
HTDCORCEPT THERAPEUTICS INC | $4.7M |
DYNDYNE THERAPEUTICS INC | $4.7M |
—ANZU SPECIAL ACQUISITIN CORP | $4.6M |
—MOLECULAR TEMPLATES INC | $4.6M |
GHGUARDANT HEALTH INC | $4.5M |
—D8 HOLDINGS CORP | $4.5M |
—OSIRIS ACQUISITION CORP | $4.5M |
BMEABIOMEA FUSION INC | $4.4M |
LZLEGALZOOM COM INC | $4.4M |
—PERIDOT ACQUISITION CORP II | $4.4M |
INFNEURINFINERA CORP | $4.3M |
—HEALTH SCIENCES ACQ CORP 2 | $4.1M |
STROSUTRO BIOPHARMA INC | $4.1M |
DOCSDOXIMITY INC | $4.1M |
AVIRATEA PHARMACEUTICALS INC | $4.0M |
NYTNEW YORK TIMES CO | $4.0M |
—DRAGONEER GROWTH OPT CORP II | $4.0M |
—OSPREY TECHNLGY AQUISTION CO | $4.0M |
TGTXTG THERAPEUTICS INC | $4.0M |
SRRKSCHOLAR ROCK HLDG CORP | $3.9M |
ZETAZETA GLOBAL HOLDINGS CORP | $3.9M |
—BRIGHT HEALTH GROUP INC | $3.9M |
—HUDSON EXECUTIVE INVES III | $3.9M |
DOCNDIGITALOCEAN HLDGS INC | $3.9M |
—DIGITAL TRANSFORMATN OPT COR | $3.9M |
—AUSTERLITZ ACQUISITION CORP | $3.9M |
—EARGO INC | $3.8M |
CTLTEURCATALENT INC | $3.8M |
—MOTIVE CAPITAL CORP | $3.8M |
—NAVSIGHT HLDGS INC | $3.8M |
PENPENUMBRA INC | $3.8M |
JOANJOANN INC | $3.8M |
—COLONNADE ACQUISITION CORP I | $3.8M |
—LOCUST WALK ACQUISITION CORP | $3.7M |
CERE1EURCEREVEL THERAPEUTICS HLDNG I | $3.7M |
—SUMMIT HEALTHCRE ACQUISTN CO | $3.7M |
—TURNING POINT THERAPEUTICS I | $3.7M |
OSH3EUROAK STR HEALTH INC | $3.6M |
SNDXSYNDAX PHARMACEUTICALS INC | $3.6M |
CELHCELSIUS HLDGS INC | $3.6M |
—TPG PACE BENEFICIAL II CORP | $3.5M |
—ARTISAN ACQUISITION CORP | $3.5M |
OPCHOPTION CARE HEALTH INC | $3.5M |
—VECTOR ACQUISITION CORP II | $3.5M |
MORFMORPHIC HLDG INC | $3.4M |
—LAZARD GROWTH ACQUISITION CO | $3.4M |
—FRONTIER ACQUISITION CORP | $3.4M |
GPACGLOBAL PARTNER ACQISTN CORP | $3.4M |
DLODLOCAL LTD | $3.4M |
DISHDISH NETWORK CORPORATION | $3.4M |
—ESM ACQUISITION CORPORATION | $3.4M |
—EPIZYME INC | $3.4M |
PODDINSULET CORP | $3.3M |
—BLUEBIRD BIO INC | $3.3M |
—SILVER CREST ACQUISITION COR | $3.2M |
—LONGVIEW ACQUISITION CORP II | $3.2M |
RNAAVIDITY BIOSCIENCES INC | $3.2M |
—ATHENA TECHNOLOGY ACQUISI CO | $3.2M |
—FUSION ACQUISITION CORP II | $3.1M |
MLB1MERCADOLIBRE INC | $3.1M |
TDUPTHREDUP INC | $3.1M |
—SANDBRIDGE ACQUISITION CORP | $3.0M |
—TALARIS THERAPEUTICS INC | $3.0M |
GHRSGH RESEARCH PLC | $3.0M |
—DHB CAPITAL CORP | $3.0M |
—OMEGA ALPHA SPAC | $3.0M |
—VALOR LATITUDE ACQUISITN COR | $3.0M |
—GORES METROPOULOS II INC | $3.0M |
—FOREST ROAD ACQUISITION COR | $2.9M |
ABMDEURABIOMED INC | $2.9M |
—THUNDER BRIDGE CAP PRTNRS II | $2.9M |